On September 22, 2025, Canadian Senator Mohamed-Iqbal Ravalia convened a High-Level Meeting on AMR in collaboration with the Canadian Antimicrobial Innovation Coalition (CAIC), with support from Innovative Medicines Canada, International Federation of Pharmaceutical Manufacturers and Associations, AMR Action Fund and GSK. The meeting gathered over 100 leaders from government, science, industry, and civil society — including representatives from G7 countries, the World Health Organization (WHO), and the European Commission — to achieve greater alignment on policy incentives to mitigate the impact of AMR in our societies.
Event Photos
